Metformin C4 Health (Metformin Hydrochloride)

Metformin lowers blood glucose primarily by inhibiting hepatic gluconeogenesis, reducing intestinal glucose absorption, and enhancing peripheral insulin sensitivity through activation of AMP‑activated protein kinase (AMPK). These mechanisms lower circulating glucose without increasing insulin secretion.

The dosage of Metformin C4 Health is individualized. A qualified prescriber determines the appropriate strength, frequency, and titration schedule based on the patient’s clinical condition, renal function, and response to therapy.

Safety data for metformin in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metformin belongs to the Biguanide class and is often first‑line therapy for type 2 diabetes because it improves insulin sensitivity without causing weight gain. Compared with sulfonylureas, it has a lower risk of hypoglycaemia, and unlike insulin, it is administered orally.

Metformin C4 Health should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency.

Metformin C4 Health is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water and not crushed or chewed unless otherwise directed by a healthcare professional.

The most serious adverse event is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, heart failure, or excessive alcohol intake. Prompt medical attention is required if symptoms such as unexplained fatigue, muscle pain, or rapid breathing develop.

Metformin C4 Health is contraindicated in patients with known hypersensitivity to metformin, severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those receiving certain contrast agents without appropriate precaution.